piracetam has been researched along with Cancer of Ovary in 5 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kwiecińska, P | 3 |
Wróbel, A | 1 |
Taubøll, E | 3 |
Gregoraszczuk, EŁ | 1 |
Halbert, RK | 1 |
Mataam, K | 1 |
Ilboudo, JC | 1 |
Gazaigne, L | 1 |
Wafo, E | 1 |
Angenard, F | 1 |
Gregoraszczuk, EL | 2 |
5 other studies available for piracetam and Cancer of Ovary
Article | Year |
---|---|
Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Female; Histone Deacetylase 2; Histone Deacetylase Inhibito | 2014 |
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Study.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Anticonvulsants; Cyclophosphamide; Fatal Out | 2016 |
[Two cases of autoimmune encephalitis with antibodies to N-methyl-D-aspartate receptor in intensive care].
Topics: Adrenal Cortex Hormones; Adult; Anticonvulsants; Autoimmune Diseases of the Nervous System; Critical | 2012 |
Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line.
Topics: Anticonvulsants; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female | 2012 |
Comparison of the effects of valproic acid and levetiracetam on apoptosis in the human ovarian cancer cell line OVCAR-3.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Far-Western; Caspase 3; Caspase 8; Caspase 9; Cell Line, | 2012 |